PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Location
San Jose, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 891% % 22%
Quick Ratio 121% % 24%
Debt-to-equity 33% % -30%
Return On Equity -22% % 44%
Return On Assets -16% % 37%
Operating Margin -31% % 42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55,878,589 shares 7.1%
Common Stock, Shares, Outstanding 55,870,000 shares 7.1%
Entity Public Float $3,100,000,000 USD 121%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 55,727,000 shares 7.1%
Weighted Average Number of Shares Outstanding, Diluted 55,727,000 shares 7.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $299,907,000 USD 50%
Cost of Revenue $106,322,000 USD 25%
Research and Development Expense $67,287,000 USD 9%
Operating Income (Loss) $92,529,000 USD 13%
Net Income (Loss) Attributable to Parent $84,582,000 USD 15%
Earnings Per Share, Basic -1 USD/shares 22%
Earnings Per Share, Diluted -1 USD/shares 22%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $294,281,000 USD 50%
Accounts Receivable, after Allowance for Credit Loss, Current $84,504,000 USD 22%
Inventory, Net $66,715,000 USD 31%
Assets, Current $454,752,000 USD 41%
Property, Plant and Equipment, Net $30,022,000 USD 13%
Operating Lease, Right-of-Use Asset $17,904,000 USD -7.1%
Other Assets, Noncurrent $5,098,000 USD 308%
Assets $511,541,000 USD 37%
Accounts Payable, Current $11,118,000 USD -26%
Contract with Customer, Liability, Current $10,665,000 USD 33%
Liabilities, Current $53,898,000 USD 0.47%
Operating Lease, Liability, Noncurrent $25,225,000 USD -7.8%
Other Liabilities, Noncurrent $576,000 USD 20%
Liabilities $131,265,000 USD -1.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $42,000 USD
Retained Earnings (Accumulated Deficit) $611,711,000 USD -16%
Stockholders' Equity Attributable to Parent $380,276,000 USD 58%
Liabilities and Equity $511,541,000 USD 37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $16,980,000 USD 47%
Net Cash Provided by (Used in) Financing Activities $1,298,000 USD -50%
Net Cash Provided by (Used in) Investing Activities $1,836,000 USD 5.7%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 55,870,000 shares 7.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $17,518,000 USD 45%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $297,319,000 USD 49%
Interest Paid, Excluding Capitalized Interest, Operating Activities $885,000 USD -12%
Deferred Tax Assets, Valuation Allowance $156,145,000 USD 29%
Deferred Tax Assets, Gross $160,800,000 USD 27%
Operating Lease, Liability $27,360,000 USD -6.3%
Payments to Acquire Property, Plant, and Equipment $1,836,000 USD -5.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $84,522,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid $37,557,000 USD -10%
Property, Plant and Equipment, Gross $42,219,000 USD 26%
Operating Lease, Liability, Current $2,135,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,808,000 USD 8.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,426,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,197,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,952,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $96,477,000 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $4,719,000 USD 39%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,101,000 USD 3%
Additional Paid in Capital $991,945,000 USD 29%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $1,475,000 USD 25%
Deferred Tax Assets, Net of Valuation Allowance $4,655,000 USD -6.1%
Share-based Payment Arrangement, Expense $45,847,000 USD 65%
Interest Expense $4,154,000 USD -11%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%